| Metric | შპს ვისტამედი | შპს ნეოლაბი | შპს თბილისის ცენტრალური ლაბორატორია |
|---|---|---|---|
| Growth | |||
| Revenue | ₾2.6m₾2.3m | ₾2.3m₾1.9m | ₾3.0m₾3.1m |
| Revenue growth | 13.9% | 21.5% | -3.3% |
| Profitability | |||
| EBITDA | ₾443k₾303k | -₾632k-₾787k | ₾318k₾511k |
| EBITDA margin | 16.8%13.1% | -26.9%-40.8% | 10.6%16.5% |
| Net profit | ₾409k₾256k | -₾643k | |
| ₾316k₾503k |
| Net margin | 15.5%11.0% | -27.4%-43.2% | 10.5%16.2% |
| Balance sheet | |||
| Total assets | ₾1.2m₾995k | ₾6.3m₾7.9m | ₾926k₾980k |
| Total equity | ₾1.0m₾820k | ₾6.2m₾7.7m | ₾267k₾551k |
| ROE | 39.6%31.2% | -10.4%-10.8% | 118.4%91.3% |